RU2019137430A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019137430A3 RU2019137430A3 RU2019137430A RU2019137430A RU2019137430A3 RU 2019137430 A3 RU2019137430 A3 RU 2019137430A3 RU 2019137430 A RU2019137430 A RU 2019137430A RU 2019137430 A RU2019137430 A RU 2019137430A RU 2019137430 A3 RU2019137430 A3 RU 2019137430A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17172659.9 | 2017-05-24 | ||
EP17172659.9A EP3406259A1 (en) | 2017-05-24 | 2017-05-24 | Neurotrophins for use in the treatment of hearing loss |
PCT/EP2018/063310 WO2018215414A1 (en) | 2017-05-24 | 2018-05-22 | Neurotrophins for use in the treatment of hearing loss |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2019137430A RU2019137430A (ru) | 2021-06-24 |
RU2019137430A3 true RU2019137430A3 (ru) | 2021-08-30 |
Family
ID=58772736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2019137430A RU2019137430A (ru) | 2017-05-24 | 2018-05-22 | Нейротрофины для применения в лечении тугоухости |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200155647A1 (ru) |
EP (2) | EP3406259A1 (ru) |
JP (1) | JP2020520956A (ru) |
KR (1) | KR20200011951A (ru) |
CN (1) | CN110691607A (ru) |
AU (1) | AU2018274589A1 (ru) |
BR (1) | BR112019024504A2 (ru) |
CA (1) | CA3062744A1 (ru) |
IL (1) | IL270701A (ru) |
RU (1) | RU2019137430A (ru) |
WO (1) | WO2018215414A1 (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021151013A1 (en) * | 2020-01-24 | 2021-07-29 | Otonomy, Inc. | Growth factor formulation for condition associated with otic event |
IL307622A (en) * | 2021-04-13 | 2023-12-01 | Domp? Farm S P A | Treatment of neuropathic corneal pain with NGF |
EP4316505A1 (en) * | 2022-08-05 | 2024-02-07 | Dompé farmaceutici S.p.a. | Intranasal administration of ngf for the treatment of sensorineural hearing loss |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6225282B1 (en) * | 1996-01-05 | 2001-05-01 | Genentech, Inc. | Treatment of hearing impairments |
US5929041A (en) * | 1996-02-23 | 1999-07-27 | Amgen Inc. | Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product |
US6113947A (en) * | 1997-06-13 | 2000-09-05 | Genentech, Inc. | Controlled release microencapsulated NGF formulation |
ATE257514T1 (de) | 1998-10-09 | 2004-01-15 | Scil Proteins Gmbh | Verfahren zur gewinnung von aktivem beta-ngf |
US7700111B2 (en) * | 2002-01-17 | 2010-04-20 | The Regents Of The University Of Michigan | Auditory nerve protection and re-growth |
WO2009062149A1 (en) * | 2007-11-08 | 2009-05-14 | Creighton University | Methods for maintaining inner ear neurons |
PL2907521T3 (pl) | 2011-12-19 | 2018-04-30 | Wacker Chemie Ag | Nowe mutanty prongf i ich zastosowania w wytwarzaniu beta-ngf |
BR112018001900A2 (pt) * | 2015-07-28 | 2018-09-18 | Otonomy, Inc. | composições agonistas de trkb ou trkc e métodos para o tratamento de condições óticas |
EP3328440A4 (en) * | 2015-07-28 | 2019-01-16 | Otonomy, Inc. | TREATMENT USING TRK B TRK B TRK ANTAGONISTS |
-
2017
- 2017-05-24 EP EP17172659.9A patent/EP3406259A1/en not_active Withdrawn
-
2018
- 2018-05-22 BR BR112019024504-9A patent/BR112019024504A2/pt not_active IP Right Cessation
- 2018-05-22 CA CA3062744A patent/CA3062744A1/en active Pending
- 2018-05-22 US US16/615,201 patent/US20200155647A1/en not_active Abandoned
- 2018-05-22 WO PCT/EP2018/063310 patent/WO2018215414A1/en active Application Filing
- 2018-05-22 JP JP2019564510A patent/JP2020520956A/ja active Pending
- 2018-05-22 EP EP18725242.4A patent/EP3630159A1/en not_active Withdrawn
- 2018-05-22 RU RU2019137430A patent/RU2019137430A/ru unknown
- 2018-05-22 AU AU2018274589A patent/AU2018274589A1/en not_active Abandoned
- 2018-05-22 CN CN201880033628.8A patent/CN110691607A/zh active Pending
- 2018-05-22 KR KR1020197035948A patent/KR20200011951A/ko not_active Application Discontinuation
-
2019
- 2019-11-17 IL IL270701A patent/IL270701A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN110691607A (zh) | 2020-01-14 |
JP2020520956A (ja) | 2020-07-16 |
IL270701A (en) | 2020-01-30 |
WO2018215414A1 (en) | 2018-11-29 |
US20200155647A1 (en) | 2020-05-21 |
KR20200011951A (ko) | 2020-02-04 |
RU2019137430A (ru) | 2021-06-24 |
EP3406259A1 (en) | 2018-11-28 |
BR112019024504A2 (pt) | 2020-06-23 |
EP3630159A1 (en) | 2020-04-08 |
CA3062744A1 (en) | 2018-11-29 |
AU2018274589A1 (en) | 2019-11-28 |